The Virus-Like Particles team in the Swartz Lab focuses on developing Biotechnology-based solutions using VLPs. Using the cell free protein synthesis platform, we are able to include non-natural amino acids into our VLPs allow for the direct bioconjugation of functional molecules to the surface.
We are currently using out virus-like particle platform to address a range of human health problems such as circulating tumor cell enumeration, lymphoma vaccine design, iron oxide nanoparticle delivery to prostate cancer cells, Parkinson's therapeutic delivery, and HIV vaccine design.
The VLP team currently consists of Yuan Lu, Wei Chan, Chris VanLang, Benjamin Ko, Marcus Rohovie, and Julie Fogarty
We are curators of the nanomedicine group in Mendeley.